Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study

MLA

Michael E. Weinblatt, et al. “Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study.” Arthritis Care & Research, vol. 72, Jan. 2020, pp. 176–83. EBSCOhost, https://doi.org/10.1002/acr.24071.

APA

Michael E. Weinblatt, Evo Alemao, Nancy A. Shadick, & Ying Bao. (2020). Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study. Arthritis Care & Research, 72, 176–183. https://doi.org/10.1002/acr.24071

Chicago

Michael E. Weinblatt, Evo Alemao, Nancy A. Shadick, and Ying Bao. 2020. “Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study.” Arthritis Care & Research 72 (January): 176–83. doi:10.1002/acr.24071.